Selumetinib (INN), sold under the brand name Koselugo, is a medication for the treatment of children, two years of age and older, with neurofibromatosis...
26 KB (2,192 words) - 08:10, 1 July 2024
Neurofibromatosis type I (section Selumetinib)
always be considered against its risks. Some NF tumours are inoperable. Selumetinib, is a drug produced by Astra Zeneca sold under the brand name Koselugo...
58 KB (6,749 words) - 13:25, 1 November 2024
treatment of advanced melanoma with a BRAF V600E or V600K mutation. Selumetinib, had a phase 2 clinical trial for non-small cell lung cancer (NSCLC)...
6 KB (719 words) - 23:12, 12 May 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
56 KB (5,566 words) - 13:30, 2 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
86 KB (7,963 words) - 18:33, 12 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
53 KB (4,975 words) - 03:43, 30 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
91 KB (9,261 words) - 06:16, 10 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
79 KB (6,427 words) - 02:51, 8 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
10 KB (778 words) - 01:56, 27 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
42 KB (3,486 words) - 00:32, 30 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
16 KB (1,284 words) - 04:32, 23 September 2024
inhibitor - Approved 2022, collaboration with Mirati Therapeutics KOSELUGO (Selumetinib) - MEK1/2 inhibitor - Approved 2020, licensed by Astrazeneca VITRAKVI...
3 KB (184 words) - 15:23, 7 August 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
22 KB (2,320 words) - 13:06, 15 August 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
31 KB (2,777 words) - 08:32, 19 October 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
10 KB (836 words) - 03:56, 30 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
24 KB (1,917 words) - 17:27, 12 October 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
14 KB (1,368 words) - 21:56, 12 September 2024
to be highly toxic and cause diarrhea. Another investigated drug is selumetinib, a MAPK inhibitor. It improved survival, but did not correlate with any...
198 KB (21,235 words) - 14:14, 7 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
31 KB (2,632 words) - 22:56, 26 October 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
42 KB (3,798 words) - 21:12, 26 October 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
6 KB (352 words) - 17:16, 16 May 2024
(USAN) Selpak selprazine (INN) Selsun Selsun Blue seltraposin (INN) selumetinib (USAN) selurampanel (INN) selvacovatein (INN) semagacestat (USAN, INN)...
7 KB (370 words) - 22:19, 30 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
8 KB (511 words) - 15:46, 7 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
4 KB (157 words) - 04:54, 31 July 2024
Lestaurtinib Momelotinib Pacritinib Ruxolitinib MAP2K Binimetinib Cobimetinib Selumetinib Trametinib EML4-ALK Crizotinib Entrectinib Lorlatinib Bruton's Acalabrutinib...
12 KB (821 words) - 02:57, 12 October 2024
inhibitors include cobimetinib, CI-1040, PD0325901, binimetinib (MEK162), selumetinib, and trametinib (GSK1120212) It has been found that acupoint-moxibustion...
24 KB (3,068 words) - 07:21, 7 June 2024
Lorlatinib L01EE01 Trametinib L01EE02 Cobimetinib L01EE03 Binimetinib L01EE04 Selumetinib L01EF01 Palbociclib L01EF02 Ribociclib L01EF03 Abemaciclib L01EG01 Temsirolimus...
12 KB (877 words) - 15:36, 25 January 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
33 KB (3,121 words) - 08:30, 1 July 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
10 KB (799 words) - 13:28, 4 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
12 KB (1,328 words) - 21:48, 20 November 2023